UBS Group AG - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 19 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10100
-98.2%
0.00%
Q3 2022$0
-100.0%
5,606
+94.1%
0.00%
Q4 2021$5,0002,8880.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,485$8,1360.00%
Shaolin Capital Management LLC 465,717$330.00%
WOLVERINE ASSET MANAGEMENT LLC 12,765$8930.00%
MORGAN STANLEY 148,939$10,4260.00%
Walleye Trading LLC 15,505$1,0850.00%
Walleye Capital LLC 23,258$1,6280.00%
Tower Research Capital LLC (TRC) 48$40.00%
LMR Partners LLP 539,588$37,7710.00%
NewEdge Advisors, LLC 1,072$750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders